Azurity Pharmaceuticals is recalling approximately 59,567 vials of Testosterone Cypionate Injection, USP, CIII (200 mg/mL), a prescription medication used to treat low testosterone levels. The recall was initiated because customers reported that crystals formed within the medication and would not dissolve back into the solution even after warming and shaking the vials. If you use this medication, you should consult your doctor or pharmacist to determine if your supply is affected.
Injecting a solution that contains undissolved crystals can cause serious health risks, including local irritation or inflammation at the injection site. If the crystals enter the bloodstream, they could potentially block small blood vessels, leading to more severe complications. No injuries or adverse events have been reported to date.
You have 2 options:
Distributed by Wilshire Pharmaceuticals, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.